Alnylam Pharmaceuticals, Inc.Alnylam Pharmaceuticals, Inc.Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

No trades
See on Supercharts

Price target

305.770.000.00%
The 26 analysts offering 1 year price forecasts for ALNY have a max estimate of — and a min estimate of —.

Analyst rating

Based on 33 analysts giving stock ratings to ALNY in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


ALNY EPS for the last quarter is −0.87 USD despite the estimation of −0.92 USD. In the next quarter EPS is expected to reach −0.59 USD. Track more of Alnylam Pharmaceuticals, Inc. financials and stay on top of what is up with the company.
In the next quarter Alnylam Pharmaceuticals, Inc. revenue is expected to reach ‪579.59 M‬ USD. Check out Alnylam Pharmaceuticals, Inc. revenue and earnings and make informed decisions.
According to analysts, ALNY price target is 305.77 USD with a max estimate of 400.00 USD and a min estimate of 178.00 USD. Check if this forecast comes true in a year, meanwhile watch Alnylam Pharmaceuticals, Inc. stock price chart and keep track of the current situation with ALNY news and stock market news.
We've gathered opinions of 33 analysts rating ALNY stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.